by Jessica Emmerson | Jun 6, 2024 | Research, Study results
BSRBR-RA study blog BSRBR-RA Study website ? New results from the study: Research on bDMARDs and Rheumatoid Arthritis We are happy to share our latest research findings: ‘Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment...
by Jessica Emmerson | May 23, 2024 | Biologic Therapy, Research
Read about some of the recent research from that BSRBR-RA looking at biosimilars. Lianne, you did the research, tell us about yourself…Hello, my name is Lianne, I am an epidemiologist at the University of Manchester. For the past 12 years I have been a researcher...
by Jessica Emmerson | May 16, 2024 | Associate principal investigator scheme
The Associate Principal Investigator Scheme Experience The BSRBR-RA Study (UK CRN ID: 7302) is part of the NIHR Associate Principal Investigator Scheme. We asked George Nowell, a rheumatology speciality trainee at Stockport NHS Foundation Trust, about his experience...
by Jessica Emmerson | Apr 16, 2024 | Uncategorised
BSRBR-RA study blog BSRBR-RA Study website ? Join Us at the BSR Rheumatology Conference 24-26 April 2024! We are thrilled to extend a warm invitation to join our sessions at the BSR’s Rheumatology conference. Held between 24th – 26th April 2024 at the ACC in...
by Jessica Emmerson | Apr 10, 2024 | Biologic Therapy, Rheumatoid Arthritis
BSRBR-RA study blog BSRBR-RA Study website ? Tyenne (tocilizumab) – the new biosimilar on the block What is Tyenne? Tyenne is the first tocilizumab (interleukin-6) biosimilar that has recently been approved by the European Medicines Agency (EMA) for the...
Recent Comments